BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1549677)

  • 21. Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
    Mehta RC; Pike GB; Haros SP; Enzmann DR
    Radiology; 1995 Apr; 195(1):41-6. PubMed ID: 7892492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
    Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
    Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas.
    Hamed MM; Hamm B; Ibrahim ME; Taupitz M; Mahfouz AE
    AJR Am J Roentgenol; 1992 Feb; 158(2):303-7. PubMed ID: 1729787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
    van Bree H; Van Ryssen B; Degryse H; Ramon F
    Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal epidural abscess: evaluation with gadolinium-enhanced MR imaging.
    Numaguchi Y; Rigamonti D; Rothman MI; Sato S; Mihara F; Sadato N
    Radiographics; 1993 May; 13(3):545-59; discussion 559-60. PubMed ID: 8316663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
    Fernandez MP; Bernardino ME; Neylan JF; Olson RA
    AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
    Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Agnoli AL; Herrmann S
    Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
    Barkhof F; Heijboer RJ; Algra PR
    AJR Am J Roentgenol; 1992 May; 158(5):1171. PubMed ID: 1566688
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*-weighted MR images.
    Tzika AA; Massoth RJ; Ball WS; Majumdar S; Dunn RS; Kirks DR
    Radiology; 1993 May; 187(2):449-58. PubMed ID: 8475289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
    Mirowitz SA
    Radiology; 1992 Nov; 185(2):529-34. PubMed ID: 1410367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
    Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
    AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
    Wenz F; Rempp K; Hess T; Debus J; Brix G; Engenhart R; Knopp MV; van Kaick G; Wannenmacher M
    AJR Am J Roentgenol; 1996 Jan; 166(1):187-93. PubMed ID: 8571873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal lesions: quantitative and qualitative temporal evolution of gadopentetate dimeglumine enhancement in MR imaging.
    Sze G; Bravo S; Krol G
    Radiology; 1989 Mar; 170(3 Pt 1):849-56. PubMed ID: 2916042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.